[go: up one dir, main page]

WO1998017266A3 - Pharmaceutical preparation - Google Patents

Pharmaceutical preparation Download PDF

Info

Publication number
WO1998017266A3
WO1998017266A3 PCT/EP1997/005724 EP9705724W WO9817266A3 WO 1998017266 A3 WO1998017266 A3 WO 1998017266A3 EP 9705724 W EP9705724 W EP 9705724W WO 9817266 A3 WO9817266 A3 WO 9817266A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical preparation
trypanosomiasis
prevention
treatment
procaine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1997/005724
Other languages
German (de)
French (fr)
Other versions
WO1998017266A2 (en
Inventor
Alain Jacques Bourdichon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU49482/97A priority Critical patent/AU4948297A/en
Priority to EP97912195A priority patent/EP0936907A2/en
Publication of WO1998017266A2 publication Critical patent/WO1998017266A2/en
Publication of WO1998017266A3 publication Critical patent/WO1998017266A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The object of the invention is to produce a pharmaceutical preparation as a treatment for the prevention of trypanosomiasis. To that end, the invention proposes a pharmaceutical preparation as a treatment for the prevention of trypanosomiasis which is characterized in that it contains at least one compound which is effective against protozoa and is selected from the group comprising amidines and procaine, or a procaine derivative.
PCT/EP1997/005724 1996-10-18 1997-10-17 Pharmaceutical preparation Ceased WO1998017266A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU49482/97A AU4948297A (en) 1996-10-18 1997-10-17 Pharmaceutical preparation
EP97912195A EP0936907A2 (en) 1996-10-18 1997-10-17 Pharmaceutical preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE29618094.7 1996-10-18
DE29618094U DE29618094U1 (en) 1996-10-18 1996-10-18 Pharmaceutical preparation

Publications (2)

Publication Number Publication Date
WO1998017266A2 WO1998017266A2 (en) 1998-04-30
WO1998017266A3 true WO1998017266A3 (en) 1998-06-25

Family

ID=8030722

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/005724 Ceased WO1998017266A2 (en) 1996-10-18 1997-10-17 Pharmaceutical preparation

Country Status (4)

Country Link
EP (1) EP0936907A2 (en)
AU (1) AU4948297A (en)
DE (1) DE29618094U1 (en)
WO (1) WO1998017266A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19853937A1 (en) * 1998-11-24 2000-05-25 Chambord Ltd Composition useful for treating e.g. malaria, babesiosis and trypanosomiasis comprises diminazene diaceturate and procaine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4309415A1 (en) * 1993-03-19 1994-09-22 Alan Jacques Bourdichon Pharmaceutical product
EP0643964A2 (en) * 1993-08-18 1995-03-22 Medipharma S.A. Use of local anesthetics for the manufacture of a medicament for the protection of plasma cell membranes
WO1997006769A2 (en) * 1995-08-21 1997-02-27 Bourdichon Alain Jacques Pharmaceutical composition with trypanocidal properties

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4309415A1 (en) * 1993-03-19 1994-09-22 Alan Jacques Bourdichon Pharmaceutical product
EP0643964A2 (en) * 1993-08-18 1995-03-22 Medipharma S.A. Use of local anesthetics for the manufacture of a medicament for the protection of plasma cell membranes
WO1997006769A2 (en) * 1995-08-21 1997-02-27 Bourdichon Alain Jacques Pharmaceutical composition with trypanocidal properties

Also Published As

Publication number Publication date
WO1998017266A2 (en) 1998-04-30
EP0936907A2 (en) 1999-08-25
AU4948297A (en) 1998-05-15
DE29618094U1 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
WO1998006742A3 (en) Peptides for treatment of inflammation and shock
ZA200110504B (en) Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria.
IL125735A (en) Pharmaceutical compositions for the treatment of glaucoma comprising an inhibitor of serine-threonine kinase, tyrosine kinase or protein tyrosine phosphatase or an actin-disrupting compound
AU2001260400A1 (en) Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
EP0825867A4 (en) N,o-carboxymethylchitosan for prevention of surgical adhesions
CA2250372A1 (en) 6-phenylpyridyl-2-amine derivatives
AU4592897A (en) Dfmo for the treatment or prevention of cervical intraepithelial neoplasia
AU1440395A (en) Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
AU2001236791A1 (en) Systems for the prevention or treatment of carpal tunnel syndrome
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
ZA9811507B (en) Combination effective for the treatment of impotence.
AU4203297A (en) The use of proteinase inhibitors for prevention or reduction of bone resorption
AU1067599A (en) Peptide compositions for the treatment and prevention of hiv infection
WO2002028829A3 (en) Peptide deformylase inhibitors
CA2321687A1 (en) Combination of a selective nmda nr2b antagonist and a cox-2 inhibitor
AU5636300A (en) Use of creatine or creatine analogs for the prevention and treatment of transmissible spongiform encephalopathies
EP1032556A4 (en) Pharmaceutically active compounds and methods of use
CA2270469A1 (en) Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
PL354413A1 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts ofginkgo biloba
ZA97252B (en) Compositions for the prevention and treatment of osteoporosis.
AU3899893A (en) Compositions for the treatment of acute or chronic inflammation
EP0676951A4 (en) Use of vitamin d glycosides for the treatment or prevention of osteoporosis.
WO2000040232A3 (en) Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997912195

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997912195

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1997912195

Country of ref document: EP